Literature DB >> 1900522

Tumor necrosis factor and granulocyte macrophage-colony stimulating factor stimulate human macrophages to restrict growth of virulent Mycobacterium avium and to kill avirulent M. avium: killing effector mechanism depends on the generation of reactive nitrogen intermediates.

M Denis1.   

Abstract

An avirulent and a virulent strain of Mycobacterium avium were selected on the basis of their growth patterns in human monocyte-derived macrophages. The virulent 7497 M. avium grew progressively in untreated macrophages, whereas the avirulent LR/149 M. avium was killed to a moderate extent by untreated human macrophages (50% of the original infectious inoculum killed 7 days after infection). We set out to investigate the possibility of modulating these growth patterns by cytokine treatment. Application of tumor necrosis factor (TNF) (100 U/ml) led to macrophages restricting significantly the growth of virulent M. avium 7497 (tenfold decrease at 7 days). TNF was also effective at modulating positively the interaction between avirulent LR/149 M. avium and macrophages inasmuch as TNF-treated cells killed 99% of infecting mycobacteria at 7 days. Granulocyte macrophage-colony stimulating factor (GM-CSF) (100-10,000 U/ml) treatment led to macrophages being as mycobacteriostatic for virulent 7497 M. avium as TNF-alpha-treated cells (i.e., tenfold reduction in growth). Treatment of macrophages with both GM-CSF and TNF-alpha was shown to have additive effects on bacteriostatic activity on M. avium. The mechanism of killing of avirulent M. avium by TNF-alpha was shown to be dependent on the generation of reactive nitrogen intermediates, as seen by inhibition of effector mechanisms by NG-monomethyl-arginine and arginase. Moreover, there was a correlation between NO2- generation and mycobactericidal activity of macrophages. Addition of superoxide dismutase reversed the killing of avirulent M. avium by untreated or TNF-treated macrophages. This abrogation was also apparent in chronic granulomatous disease (CGD) macrophages, which were inefficient at generating reactive oxygen intermediates. Moreover, macrophages from CGD patients killed avirulent M. avium as efficiently as cells from normal individuals. We conclude from these results that 1) GM-CSF and TNF-alpha, alone or in combination, increase effector functions of macrophages against virulent and avirulent strains of M. avium; 2) reactive nitrogen intermediates seem to be involved in this effector mechanism; and 3) superoxide dismutase protected M. avium against macrophage effector function, seemingly by protecting the bacteria against endogenous superoxide anion. The implications of these findings for host resistance to atypical mycobacteria are discussed.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1900522     DOI: 10.1002/jlb.49.4.380

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  97 in total

1.  Cytokine-induced expression of a nitric oxide synthase in rat renal tubule cells.

Authors:  B A Markewitz; J R Michael; D E Kohan
Journal:  J Clin Invest       Date:  1993-05       Impact factor: 14.808

2.  In vivo expression of inducible nitric oxide synthase in experimentally induced neurologic diseases.

Authors:  H Koprowski; Y M Zheng; E Heber-Katz; N Fraser; L Rorke; Z F Fu; C Hanlon; B Dietzschold
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-01       Impact factor: 11.205

3.  The killing of Leishmania major by human macrophages is mediated by nitric oxide induced after ligation of the Fc epsilon RII/CD23 surface antigen.

Authors:  I Vouldoukis; V Riveros-Moreno; B Dugas; F Ouaaz; P Bécherel; P Debré; S Moncada; M D Mossalayi
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-15       Impact factor: 11.205

4.  Human and rat macrophages mediate fungistatic activity against Rhizopus species differently: in vitro and ex vivo studies.

Authors:  P G Jorens; J R Boelaert; V Halloy; R Zamora; Y J Schneider; A G Herman
Journal:  Infect Immun       Date:  1995-11       Impact factor: 3.441

5.  Nitric oxide production and inducible nitric oxide synthase expression in inflammatory arthritides.

Authors:  H Sakurai; H Kohsaka; M F Liu; H Higashiyama; Y Hirata; K Kanno; I Saito; N Miyasaka
Journal:  J Clin Invest       Date:  1995-11       Impact factor: 14.808

6.  Live Brucella spp. fail to induce tumor necrosis factor alpha excretion upon infection of U937-derived phagocytes.

Authors:  E Caron; T Peyrard; S Köhler; S Cabane; J P Liautard; J Dornand
Journal:  Infect Immun       Date:  1994-12       Impact factor: 3.441

7.  Muramyldipeptide and granulocyte-macrophage colony-stimulating factor enhance interferon-gamma-induced nitric oxide production by rat alveolar macrophages.

Authors:  P G Jorens; F J van Overveld; H Bult; P A Vermeire; A G Herman
Journal:  Agents Actions       Date:  1993-01

8.  Mycobacterium avium-intracellulare contamination of mammalian cell cultures.

Authors:  I H Lelong-Rebel; Y Piemont; M Fabre; G Rebel
Journal:  In Vitro Cell Dev Biol Anim       Date:  2008-10-15       Impact factor: 2.416

9.  Evidence for cytokine-inducible nitric oxide synthesis from L-arginine in patients receiving interleukin-2 therapy.

Authors:  J B Hibbs; C Westenfelder; R Taintor; Z Vavrin; C Kablitz; R L Baranowski; J H Ward; R L Menlove; M P McMurry; J P Kushner
Journal:  J Clin Invest       Date:  1992-03       Impact factor: 14.808

10.  Effect of lipoarabinomannan and mycobacteria on tumour necrosis factor production by different populations of murine macrophages.

Authors:  M G Bradbury; C Moreno
Journal:  Clin Exp Immunol       Date:  1993-10       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.